Multiplicom sales and marketing update

Multiplicom launched Clarigo, a non-invasive prenatal diagnostic that detects fetal chromosomal abnormalities in chromosomes 21, 18 and 13. Clarigo, which has CE Mark approval, is based on Multiplicom...